In a mouse model of EoE, where animals are epicutaneously sensitized to ovalbumin (OVA) protein and then challenged with intranasal OVA, pathology could be abrogated by genetic ablation of ST2 or administration of anti-ST2 monoclonal antibody (mAb). The gene discussed is IL1RL1; the disease is eosinophilic esophagitis.